Alnylam Pharmaceuticals, Inc.
$219.00
$1.33(-0.60%)
ALNY
Alnylam Pharmaceuticals, Inc.
$219.00
1D:
-0.6%
1Y:
-47.7%
US02043Q1076Healthcare
Chart
Key stats
52-Week Range$219.00
$197.81
$495.55
Market capitalization
$29.30BDividend yield (indicated)
0.00%Price to earnings Ratio (TTM)
33.69Basic EPS (TTM)
$4.36Net income (TTM)
$577.22MRevenue (TTM)
$4.29BAvg. volume
1.47MBeta (1Y)
0.27Employees
2.50KMarket capitalization
$29.30BDividend yield (indicated)
0.00%Price to earnings Ratio (TTM)
33.69Basic EPS (TTM)
$4.36Net income (TTM)
$577.22MRevenue (TTM)
$4.29BAvg. volume
1.47MBeta (1Y)
0.27Employees
2.50KScreener Quick Check
Sign in to check this stock against your screeners
Sign InRelated Stocks
$760.66
1D:
0.2%
1Y:
33.1%
US75886F1075Healthcare
Mkt Cap
$78.36B
P/E Ratio TTM
18.2
Revenue TTM
$14.92B
Beta
0.24
Earnings TTM
$4.42B
Dividend Yield TTM
0.48%
$274.05
1D:
-2.8%
1Y:
2.8%
US1255231003Healthcare
Mkt Cap
$72.42B
P/E Ratio TTM
11.5
Revenue TTM
$277.94B
Beta
0.30
Earnings TTM
$6.29B
Dividend Yield TTM
2.20%